Last reviewed · How we verify
Apremilast 30mg
Apremilast 30mg is a Small molecule drug developed by Amgen. It is currently FDA-approved. Also known as: CC-10004, Otezla, Apremilast tablets.
At a glance
| Generic name | Apremilast 30mg |
|---|---|
| Also known as | CC-10004, Otezla, Apremilast tablets |
| Sponsor | Amgen |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Human Laboratory Study of Apremilast for Alcohol Use Disorder (PHASE2)
- Apremilast for Alcohol Use Disorder Treatment in Women and Men (PHASE1)
- Dose-response Study of Apremilast in Women and Men With Alcohol Use Disorder (PHASE2)
- To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital (EARLY_PHASE1)
- Efficacy and Safety of add-on Apremilast Versus add-on Methotrexate in Patients With Oral Lichen Planus (PHASE4)
- Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis
- Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients (PHASE2, PHASE3)
- Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Apremilast 30mg CI brief — competitive landscape report
- Apremilast 30mg updates RSS · CI watch RSS
- Amgen portfolio CI
Frequently asked questions about Apremilast 30mg
What is Apremilast 30mg?
Apremilast 30mg is a Small molecule drug developed by Amgen.
Who makes Apremilast 30mg?
Apremilast 30mg is developed and marketed by Amgen (see full Amgen pipeline at /company/amgen).
Is Apremilast 30mg also known as anything else?
Apremilast 30mg is also known as CC-10004, Otezla, Apremilast tablets.
What development phase is Apremilast 30mg in?
Apremilast 30mg is FDA-approved (marketed).
Related
- Manufacturer: Amgen — full pipeline
- Also known as: CC-10004, Otezla, Apremilast tablets
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing